VERA THERAPEUTICS INC. - CLASS A COMMON STOCK

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 мар 2025 16:28:05 Источник Nasdaq GlobeNewswire

Vera Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

27 фев 2025 08:00:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

26 фев 2025 08:25:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13 фев 2025 16:05:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

14 янв 2025 16:05:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics Acquires Global Rights to Novel, Next Generation Dual BAFF/APRIL Inhibitor

13 янв 2025 07:00:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

07 янв 2025 16:05:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

09 дек 2024 18:29:08 Источник Nasdaq GlobeNewswire

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

22 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer

18 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics Partners with University of Michigan on the NEPTUNE Match Project and PIONEER Study

11 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics to Participate at Upcoming Investor Conferences

08 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics to Participate at Upcoming Investor Conferences

08 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

07 ноя 2024 08:00:01 Источник Nasdaq GlobeNewswire

Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock

29 окт 2024 20:22:02 Источник Nasdaq GlobeNewswire

Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock

28 окт 2024 17:37:30 Источник Nasdaq GlobeNewswire

Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024

26 окт 2024 19:30:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 окт 2024 16:05:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases

02 окт 2024 06:30:00 Источник Nasdaq GlobeNewswire